Pharmacyclics (PCYC) Tops Q3 EPS by 32c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Pharmacyclics (PCYC) Tops Q3 EPS by 32c

Pharmacyclics (PCYC) PT Lifted to $175 at Nomura on Strong Q3

November 5, 2014 10:04 AM EST

Nomura Securities analyst M. Ian Somaiya reiterated a Buy rating and boosted its price target on Pharmacyclics (NASDAQ: PCYC) to $175.00 (from $158.00) following strong Q3 results.

Somaiya commented, "We are increasing our Imbruvica estimates and PCYC TP to $175 from $158, following strong 3Q14 results and further... More